Evidence map›Paper›PMID 38997670›Full record

SynthesisBMC geriatrics2024

Differences of anticholinergic drug burden between older hospitalized patients with and without delirium: a systematic review and meta-analysis based on prospective cohort studies.

Chifong Ieong, Tingjia Chen, Sai Chen, Xiang Gao, Kemin Yan, Wen He, Hua Hong, Yong Gu, Xiao Chen, Gang Yuan

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in BMC geriatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chifong Ieong *Department of Geriatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Tingjia Chen *Healthcare Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Sai ChenDepartment of Geriatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Xiang GaoDepartment of Geriatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Kemin YanDepartment of Geriatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Wen HeDepartment of Geriatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Hua HongDepartment of Geriatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Yong GuDepartment of Geriatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Xiao ChenDepartment of Pharmacy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Gang YuanDepartment of Geriatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. yuangang@mail.sysu.edu.cn.

Funding

Sun Yat-sen University P12220011-230148
6 · The paper itself

Abstract

objectivesThis review aims to comprehensively summarize the differences in anticholinergic drug burden (ADB) scores between older hospitalized patients with and without delirium.

methodsWe searched PubMed, Embase, Web of Science, Cochrane Library and CINAHL EBSCOhost databases to identify prospective cohort studies exploring the relationship between ADB and the occurrence of delirium in older hospitalized patients. The primary outcome of the review was the mean ADB scores for the delirium and non-delirium groups, and the secondary outcome was the scores for the subsyndromal and non-delirium groups. The standardized mean difference (SMD) and corresponding 95% confidence intervals (95% CI) were incorporated using a fixed-effect method. Moreover, we performed subgroup analysis according to the admission type, age, the ADB scale type and the ADB classification.

resultsNine prospective cohort studies involving 3791 older patients with a median age of 75.1 (71.6-83.9) were included. The ADB score was significantly higher in the delirium group than in the non-delirium group (SMD = 0.21, 95%CI 0.13-0.28). In subgroup analysis, the age subgroup was split into < 75 and ≥ 75 according to the median age of the older people. There were significant differences in ADB scores between older people with delirium and those without delirium in various subgroups: surgical (SMD = 0.20, 95%CI 0.12-0.28), internal medicine (SMD = 0.64, 95%CI 0.25-1.02), age < 75 (SMD = 0.17, 95%CI 0.08-0.26), age ≥ 75 (SMD = 0.27, 95%CI 0.15-0.39), ADS scale (SMD = 0.13, 95%CI 0.13-0.40), ARS scale (SMD = 0.15, 95%CI 0.03-0.26), ACB scale (SMD = 0.13, 95%CI 0.01-0.25), pre-admission ADB (SMD = 0.24, 95%CI 0.05-0.43) and ADB during hospitalization (SMD = 0.20, 95%CI 0.12-0.27).

conclusionsWe found a quantitative relationship between ADB and delirium in older patients admitted for internal medicine and surgery. And this relationship remained significant in different age, ADB scale type and ADB classification subgroups. However, the actual difference in ADB scores between patients with delirium and without delirium was small. More high-quality observational studies should be conducted to explore the impact of ADB on delirium and subsyndromal delirium. CLINICAL

trial registrationThe protocol was published in the International Prospective Register of Systematic Reviews (PROSPERO) [Ref: CRD42022353649].

Indexed as

Cholinergic AntagonistsDeliriumHospitalizationAgedAged, 80 and overCohort StudiesHumansProspective StudiesCholinergic AntagonistsAnticholinergic drug burdenDeliriumMeta-analysisOlder hospitalized patientsRelationship

Identifiers

PMID38997670
PMCPMC11241997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.